[ET Net News Agency, 29 April 2025] EVEREST MED-B (01952) rose 10.8% to HK$49.4.
It hits an intra-day high of HK$49.4, breaking above the 100-D SMA of HK$47.114, and an
intra-day low of HK$44.7. The total shares traded was 5.26 million, with a value of
HK$245.14m. The active buy/sell ratio is 67:33, with net buying turnover of HK$79.39m.
J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$2.83m,
with volume weighted average price of HK$47.103. CHINA INNOVATION MARKET SER accounts for
greatest net responsive selling turnover of HK$18.36m, with volume weighted average price
of HK$46.59.

Basic Information
=================

----------------------------------
Nominal 49.400 % Chg +10.76%
High 49.400 Low 44.700
Shares Tr 5.26m Turnover 245.14m
10-D SMA 47.870 %H.V 107.470
20-D SMA 49.448 VWAP 46.591
50-D SMA 50.788 RSI14 49.524
----------------------------------
Status: Breaking above the 100-D SMA, active buy/sell ratio is 67:33, with net buying
turnover of HK$79.39m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
EVEREST MED-B (01952) 49.40 +10.76
INNOVENT BIO (01801) 53.65 -1.01
XTALPI (02228) 5.01 -1.57
WUXI BIO (02269) 23.10 +1.09
WUXI APPTEC (02359) 60.50 +3.95
BEIGENE (06160) 148.60 +1.30
SKB BIO-B (06990) 331.40 +9.59
ZAI LAB (09688) 24.55 -0.61
AKESO (09926) 87.30 +0.11
REMEGEN (09995) 37.35 -9.78
---------------------------------------------
(ed)